Literature DB >> 26294789

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.

Vito Annese1, Laurent Beaugerie2, Laurence Egan3, Livia Biancone4, Claus Bolling5, Christian Brandts6, Daan Dierickx7, Reinhard Dummer8, Gionata Fiorino9, Jean Marc Gornet10, Peter Higgins11, Konstantinos H Katsanos12, Loes Nissen13, Gianluca Pellino14, Gerhard Rogler15, Franco Scaldaferri16, Edyta Szymanska17, Rami Eliakim18.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26294789     DOI: 10.1093/ecco-jcc/jjv141

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  87 in total

1.  Anal Squamous Cell Carcinoma: An Infrequent Challenge in the Management of Ulcerative Colitis Under Combination Therapy.

Authors:  Paulo Gustavo Kotze; Patricia Zacharias
Journal:  J Crohns Colitis       Date:  2016-01-27       Impact factor: 9.071

Review 2.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 3.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

4.  Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine.

Authors:  Koichi Sato; Tomoaki Suga; Atsuhiro Hirayama; Seiichi Daikuhara; Takeshi Uehara; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2019-07-26

5.  Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Dejan Micic; Yuga Komaki; Aleksandar Alavanja; David T Rubin; Atsushi Sakuraba
Journal:  J Clin Gastroenterol       Date:  2019-01       Impact factor: 3.062

Review 6.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 7.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Authors:  G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-14       Impact factor: 3.781

8.  Adalimumab therapy in a patient with Crohn's disease with a giant pelvic paraganglioma after chemotherapy.

Authors:  Tsutomu Mizoshita; Masashi Ando; Hiroyuki Sagawa; Yoshinori Mori; Takahito Katano; Keiji Ozeki; Satoshi Tanida; Yasuyuki Okamoto; Takaya Shimura; Eiji Kubota; Hiromi Kataoka; Takeshi Kamiya; Takashi Joh
Journal:  Clin J Gastroenterol       Date:  2017-03-07

Review 9.  Novel biomarkers of fibrosis in Crohn's disease.

Authors:  Gianluca Pellino; Pierlorenzo Pallante; Francesco Selvaggi
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 10.  Colorectal cancer in inflammatory bowel disease: review of the evidence.

Authors:  D S Keller; A Windsor; R Cohen; M Chand
Journal:  Tech Coloproctol       Date:  2019-01-30       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.